The de novo design of small proteins with beta-barrel topologies has been a challenge for…
sciencecityMarch 16, 2023
Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed. Whether…
sciencecityMarch 16, 2023
Cambridge, Mass.-based biotech company Moderna is opening an office in Seattle to build up its…
sciencecityMarch 16, 2023
Pfizer is spending about $43 billion to acquire Seagen, the Bothell-based biotech giant formerly known…
sciencecityMarch 15, 2023
In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT…
sciencecityMarch 14, 2023
March is Women's History Month and we're celebrating by talking with some of our institute's directors. The…
sciencecityMarch 13, 2023
There are few complications of bone marrow transplantation more dangerous than a viral infection that…
sciencecityMarch 10, 2023
The Access to Advanced Health Institute (AAHI) published the results of a Phase I clinical…
sciencecityMarch 9, 2023
Only a decade ago, many in oncology considered chimeric antigen receptor T-cell therapy too fringe…
sciencecityMarch 8, 2023
